USD 5.18 Bn growth in In-Vitro Toxicity Testing Market | North America to witness huge growth

The global in-vitro toxicity testing market is fragmented and is characterized by the presence of…

The global in-vitro toxicity testing market is fragmented and is characterized by the presence of several global and regional vendors. Vendors in the market are investing in technologies to develop innovative, energy-efficient, and advanced in-vitro toxicity testing products that can be used in all applications across various end-user industries. Vendors are also focusing on organic and inorganic strategies such as technological innovations and mergers and acquisitions (M&A), to strengthen their position in the market. Technavio identifies Abbott Laboratories, Agilent Technologies Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Laboratory Corp. of America Holdings, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc. as dominant players in the market.

Although the increasing use of in-vitro toxicity testing by companies to reduce drug failures, the presence of toxic substances, and the rising number of awareness programs will offer immense growth opportunities, limitations of preclinical studies and the presence of stringent regulations will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy our full report to get detailed insights on the successful business strategies adopted by leading vendors and the factors impacting their growth. Read Our Report Sample Before Purchasing

In-Vitro Toxicity Testing Market 2022-2026: Segmentation

The global in-vitro toxicity testing market is segmented as below:

  • End-User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutions
    • Others

The pharmaceutical and biotechnology companies are the prime end-users in the market. The increase in the development of genetically engineered hormones, enzymes, antibodies, and vaccines for the treatment of various diseases is driving the growth of the segment. The market growth in the segment will be significant over the forecast period.

  • Geographic
    • North America
    • Europe
    • Asia
    • ROW

North America will have the largest share of the market. The region will contribute 39% of the global market growth. Increasing outsourcing of drug development processes to CROs is driving the growth of the regional market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our in-vitro toxicity testing market report covers the following areas:

In-Vitro Toxicity Testing Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the in-vitro toxicity testing market. Backed with competitive intelligence and benchmarking, our research report on the in-vitro toxicity testing market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

In-Vitro Toxicity Testing Market 2022-2026: Key Highlights

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will assist in-vitro toxicity testing market growth during the next five years
  • Estimation of the in-vitro toxicity testing market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the in-vitro toxicity testing market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of in-vitro toxicity testing market vendors

Related Reports:

Biopharmaceutical Analytical Testing Services Market by End-user and Geography – Forecast and Analysis 2021-2025

Drugs of Abuse Testing Market by Product and Geography – Forecast and Analysis 2022-2026

In-Vitro Toxicity Testing Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 10.09%

Market growth 2022-2026

USD 5.18 billion

Market structure

Fragmented

YoY growth (%)

9.68

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 39%

Key consumer countries

US, Canada, Germany, UK, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Agilent Technologies Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Laboratory Corp. of America Holdings, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents :

1 Executive Summary

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 01: Parent market
    • Exhibit 02: Market characteristics
  • 2.2 Value chain analysis
    • Exhibit 03: Value Chain Analysis: Life sciences tools and services

3 Market Sizing

  • 3.2 Market segment analysis
    • Exhibit 04: Offerings of vendors included in the market definition
  • 3.3 Market size 2021
    • Exhibit 05: Market segments
  • 3.4 Market outlook: Forecast for 2021 – 2026
    • Exhibit 06: Global – Market size and forecast 2021 – 2026 ($ million)

4 Five Forces Analysis

  • 4.2 Bargaining power of buyers
    • Exhibit 08: Five forces analysis 2021 & 2026
  • 4.3 Bargaining power of suppliers
    • Exhibit 09: Bargaining power of buyers
  • 4.4 Threat of new entrants
    • Exhibit 10: Bargaining power of suppliers
  • 4.5 Threat of substitutes
    • Exhibit 11: Threat of new entrants
  • 4.6 Threat of rivalry
    • Exhibit 12: Threat of substitutes
  • 4.7 Market condition
    • Exhibit 13: Threat of rivalry

5 Market Segmentation by End-user

  • 5.2 Comparison by End-user
    • Exhibit 15: End-user – Market share 2021-2026 (%)
  • 5.3 Pharmaceutical and biotechnology companies – Market size and forecast 2021-2026
    • Exhibit 16: Comparison by End-user
    • Exhibit 17: Pharmaceutical and biotechnology companies – Market size and forecast 2021-2026 ($ million)
  • 5.4 Academic and research institutions – Market size and forecast 2021-2026
    • Exhibit 18: Pharmaceutical and biotechnology companies – Year-over-year growth 2021-2026 (%)
    • Exhibit 19: Academic and research institutions – Market size and forecast 2021-2026 ($ million)
  • 5.5 Others – Market size and forecast 2021-2026
    • Exhibit 20: Academic and research institutions – Year-over-year growth 2021-2026 (%)
    • Exhibit 21: Others – Market size and forecast 2021-2026 ($ million)
  • 5.6 Market opportunity by End-user
    • Exhibit 22: Others – Year-over-year growth 2021-2026 (%)

6 Customer landscape

7 Geographic Landscape

  • 7.1 Geographic segmentation
    • Exhibit 25: Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison
  • 7.3 North America – Market size and forecast 2021-2026
    • Exhibit 26: Geographic comparison
    • Exhibit 27: North America – Market size and forecast 2021-2026 ($ million)
  • 7.4 Europe – Market size and forecast 2021-2026
    • Exhibit 28: North America – Year-over-year growth 2021-2026 (%)
    • Exhibit 29: Europe – Market size and forecast 2021-2026 ($ million)
  • 7.5 Asia – Market size and forecast 2021-2026
    • Exhibit 30: Europe – Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Asia – Market size and forecast 2021-2026 ($ million)
  • 7.6 ROW – Market size and forecast 2021-2026
    • Exhibit 32: Asia – Year-over-year growth 2021-2026 (%)
    • Exhibit 33: ROW – Market size and forecast 2021-2026 ($ million)
  • 7.7 Key leading countries
    • Exhibit 34: ROW – Year-over-year growth 2021-2026 (%)
  • 7.8 Market opportunity by geography
    • Exhibit 35: Key leading countries

8 Drivers, Challenges, and Trends

  • 8.3 Market trends
    • Exhibit 37: Impact of drivers and challenges

9 Vendor Landscape

  • 9.2 Landscape disruption
    • Exhibit 38: Vendor landscape
    • Exhibit 39: Landscape disruption
  • 9.3 Competitive scenario
    • Exhibit 40: Industry risks

10 Vendor Analysis

  • 10.1 Vendors covered
    • Exhibit 41: Vendors covered
  • 10.2 Market positioning of vendors
  • 10.3 Abbott Laboratories
    • Exhibit 42: Market positioning of vendors
    • Exhibit 43: Abbott Laboratories – Overview
    • Exhibit 44: Abbott Laboratories – Business segments
  • 10.4 Agilent Technologies Inc.
  • 10.5 Bio Rad Laboratories Inc.
    • Exhibit 50: Agilent Technologies Inc. – Key news
    • Exhibit 51: Agilent Technologies Inc. – Key offerings
    • Exhibit 52: Agilent Technologies Inc. – Segment focus
    • Exhibit 53: Bio Rad Laboratories Inc. – Overview
    • Exhibit 54: Bio Rad Laboratories Inc. – Business segments
    • Exhibit 55: Bio Rad Laboratories Inc. – Key news
  • 10.6 Charles River Laboratories International Inc.
    • Exhibit 56: Bio Rad Laboratories Inc. – Key offerings
    • Exhibit 57: Bio Rad Laboratories Inc. – Segment focus
    • Exhibit 58: Charles River Laboratories International Inc. – Overview
    • Exhibit 59: Charles River Laboratories International Inc. – Business segments
  • 10.7 Eurofins Scientific SE
    • Exhibit 60: Charles River Laboratories International Inc. – Key offerings
    • Exhibit 61: Charles River Laboratories International Inc. – Segment focus
    • Exhibit 62: Eurofins Scientific SE – Overview
    • Exhibit 63: Eurofins Scientific SE – Business segments
  • 10.8 Evotec SE
    • Exhibit 64: Eurofins Scientific SE – Key news
    • Exhibit 65: Eurofins Scientific SE – Key offerings
    • Exhibit 66: Eurofins Scientific SE – Segment focus
    • Exhibit 67: Evotec SE – Overview
    • Exhibit 68: Evotec SE – Business segments
  • 10.9 Laboratory Corp. of America Holdings
    • Exhibit 69: Evotec SE – Key offerings
    • Exhibit 70: Evotec SE – Segment focus
    • Exhibit 71: Laboratory Corp. of America Holdings – Overview
    • Exhibit 72: Laboratory Corp. of America Holdings – Business segments
  • 10.10 Merck KGaA
    • Exhibit 73: Laboratory Corp. of America Holdings – Key offerings
    • Exhibit 74: Laboratory Corp. of America Holdings – Segment focus
    • Exhibit 75: Merck KGaA – Overview
    • Exhibit 76: Merck KGaA – Business segments
  • 10.11 SGS SA
    • Exhibit 77: Merck KGaA– Key news
    • Exhibit 78: Merck KGaA – Key offerings
    • Exhibit 79: Merck KGaA – Segment focus
    • Exhibit 80: SGS SA – Overview
    • Exhibit 81: SGS SA – Business segments
    • Exhibit 82: SGS SA – Key news
    • Exhibit 83: SGS SA – Key offerings
    • Exhibit 84: SGS SA – Segment focus
  • 10.12 Thermo Fisher Scientific Inc.
    • Exhibit 85: Thermo Fisher Scientific Inc. – Overview
    • Exhibit 86: Thermo Fisher Scientific Inc. – Business segments

11 Appendix

  • 11.2 Currency conversion rates for US$
  • 11.3 Research methodology
    • Exhibit 90: Currency conversion rates for US$
    • Exhibit 91: Research Methodology
    • Exhibit 92: Validation techniques employed for market sizing
  • 11.4 List of abbreviations
    • Exhibit 93: Information sources
    • Exhibit 94: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio